The current standard of care for AIS is thrombolysis by intravenous recombinant tissue plasminogen activator (rtPA, alteplase) within 4.5 h of stroke onset, and endovascular therapy in selected patients within 24 h of stroke onset [4–8]. Here, PLAT is linked to Stroke.